[Migraineous anterior optic ischemic neuropathy].
METHODS
We report the case of a 22-year-old man who presented with headache and blurred vision which had started four days previous. A periventricular lesion was found in the magnetic resonance imaging. The patient was diagnosed with demyelinating neuritis and treated with intravenous methylprednisolone.


CONCLUSIONS
After six months visual function had not improved, so the initial diagnosis was probably erroneous. It is likely that the patient suffered from migraineous optic ischemic neuropathy. In this paper we review the scarce literature about this topic, and the role of migraine as a cardiovascular risk factor.
González-Martín-Moro
J
J
Servicio de Oftalmología, Hospital de la Princesa, Madrid, España. juliogmm@yahoo.es
Pilo-de-la-Fuente
B
B
Moreno-Martín
P
P
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D008076:Cholesterol, HDL / Q000172:deficiency; D003711:Demyelinating Diseases / Q000175:diagnosis*; D003951:Diagnostic Errors; D005625:Frontal Lobe / Q000473:pathology; D006801:Humans; D007238:Infarction / Q000209:etiology; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D020325:Migraine with Aura / Q000150:complications*; D009898:Optic Disk / Q000473:pathology; D018917:Optic Neuropathy, Ischemic / Q000150:complications / Q000175:diagnosis*; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D058609:Visual Field Tests; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D008076:Cholesterol, HDL; D008775:Methylprednisolone